Privacy and artificial intelligence: challenges for protecting health information in a new era

Abstract Background Advances in healthcare artificial intelligence (AI) are occurring rapidly and there is a growing discussion about managing its development. Many AI technologies end up owned and controlled by private entities. The nature of the implementation of AI could mean such corporations, c...

Full description

Bibliographic Details
Main Author: Blake Murdoch
Format: Article
Language:English
Published: BMC 2021-09-01
Series:BMC Medical Ethics
Subjects:
Online Access:https://doi.org/10.1186/s12910-021-00687-3
id doaj-2cb581cb68ec44c3bd569e37b2472b70
record_format Article
spelling doaj-2cb581cb68ec44c3bd569e37b2472b702021-09-19T11:03:53ZengBMCBMC Medical Ethics1472-69392021-09-012211510.1186/s12910-021-00687-3Privacy and artificial intelligence: challenges for protecting health information in a new eraBlake Murdoch0Health Law Institute, Faculty of Law, University of AlbertaAbstract Background Advances in healthcare artificial intelligence (AI) are occurring rapidly and there is a growing discussion about managing its development. Many AI technologies end up owned and controlled by private entities. The nature of the implementation of AI could mean such corporations, clinics and public bodies will have a greater than typical role in obtaining, utilizing and protecting patient health information. This raises privacy issues relating to implementation and data security. Main body The first set of concerns includes access, use and control of patient data in private hands. Some recent public–private partnerships for implementing AI have resulted in poor protection of privacy. As such, there have been calls for greater systemic oversight of big data health research. Appropriate safeguards must be in place to maintain privacy and patient agency. Private custodians of data can be impacted by competing goals and should be structurally encouraged to ensure data protection and to deter alternative use thereof. Another set of concerns relates to the external risk of privacy breaches through AI-driven methods. The ability to deidentify or anonymize patient health data may be compromised or even nullified in light of new algorithms that have successfully reidentified such data. This could increase the risk to patient data under private custodianship. Conclusions We are currently in a familiar situation in which regulation and oversight risk falling behind the technologies they govern. Regulation should emphasize patient agency and consent, and should encourage increasingly sophisticated methods of data anonymization and protection.https://doi.org/10.1186/s12910-021-00687-3PrivacyArtificial intelligenceBioethicsHealth law
collection DOAJ
language English
format Article
sources DOAJ
author Blake Murdoch
spellingShingle Blake Murdoch
Privacy and artificial intelligence: challenges for protecting health information in a new era
BMC Medical Ethics
Privacy
Artificial intelligence
Bioethics
Health law
author_facet Blake Murdoch
author_sort Blake Murdoch
title Privacy and artificial intelligence: challenges for protecting health information in a new era
title_short Privacy and artificial intelligence: challenges for protecting health information in a new era
title_full Privacy and artificial intelligence: challenges for protecting health information in a new era
title_fullStr Privacy and artificial intelligence: challenges for protecting health information in a new era
title_full_unstemmed Privacy and artificial intelligence: challenges for protecting health information in a new era
title_sort privacy and artificial intelligence: challenges for protecting health information in a new era
publisher BMC
series BMC Medical Ethics
issn 1472-6939
publishDate 2021-09-01
description Abstract Background Advances in healthcare artificial intelligence (AI) are occurring rapidly and there is a growing discussion about managing its development. Many AI technologies end up owned and controlled by private entities. The nature of the implementation of AI could mean such corporations, clinics and public bodies will have a greater than typical role in obtaining, utilizing and protecting patient health information. This raises privacy issues relating to implementation and data security. Main body The first set of concerns includes access, use and control of patient data in private hands. Some recent public–private partnerships for implementing AI have resulted in poor protection of privacy. As such, there have been calls for greater systemic oversight of big data health research. Appropriate safeguards must be in place to maintain privacy and patient agency. Private custodians of data can be impacted by competing goals and should be structurally encouraged to ensure data protection and to deter alternative use thereof. Another set of concerns relates to the external risk of privacy breaches through AI-driven methods. The ability to deidentify or anonymize patient health data may be compromised or even nullified in light of new algorithms that have successfully reidentified such data. This could increase the risk to patient data under private custodianship. Conclusions We are currently in a familiar situation in which regulation and oversight risk falling behind the technologies they govern. Regulation should emphasize patient agency and consent, and should encourage increasingly sophisticated methods of data anonymization and protection.
topic Privacy
Artificial intelligence
Bioethics
Health law
url https://doi.org/10.1186/s12910-021-00687-3
work_keys_str_mv AT blakemurdoch privacyandartificialintelligencechallengesforprotectinghealthinformationinanewera
_version_ 1717375933504028672